Form 4: Herbalife President Robert Levy Granted 33,301 SARs

Herbalife Ltd. President Robert Levy received a grant of 33,301 Stock Appreciation Rights with a $10.51 exercise price, vesting over three years.

Summary

• Robert Levy, President of Herbalife Ltd., was granted 33,301 Stock Appreciation Rights (SARs) on February 25, 2026.
• The SARs have an exercise price of $10.51 per share.
• These SARs will vest in one-third increments on February 25, 2027, February 25, 2028, and February 25, 2029.
• Vesting is contingent upon continued service through each respective date.
• The SARs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
• The expiration date for these SARs is February 25, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting routine executive compensation that aligns management incentives with shareholder interests, without indicating any immediate operational or financial changes.

Positives

• The grant of Stock Appreciation Rights aligns the interests of President Robert Levy with those of shareholders, as the value of the SARs increases with the company's stock price.
• Equity-based compensation is a standard practice for executive retention and motivation, encouraging long-term commitment and performance.

Negatives

• The grant of SARs does not represent an immediate cash infusion for the company.
• Potential future exercise of SARs could lead to dilution if new shares are issued, or impact cash flow if settled in cash.

Risks

• The value of the SARs is dependent on the future performance of Herbalife Ltd.'s stock price, meaning the compensation may not materialize if the stock price does not appreciate above the exercise price.
• Future dilution of existing shareholders if the SARs are exercised and settled with newly issued shares.

Future Outlook

The future value of these Stock Appreciation Rights for Robert Levy is directly tied to the appreciation of Herbalife Ltd.'s common stock above the $10.51 exercise price, with vesting scheduled incrementally over the next three years.

Industry Context

StockSavvy.ai notes that the grant of Stock Appreciation Rights is a common form of long-term incentive compensation for executives in publicly traded companies, designed to align management's financial interests with shareholder value creation. This practice is widespread across various industries, including the health and wellness sector where Herbalife operates.

Comparison to Industry Standards

• The use of Stock Appreciation Rights (SARs) as executive compensation is a standard practice, comparable to grants of stock options or restricted stock units seen at companies like GNC Holdings or USANA Health Sciences, which also operate in the health and wellness product space.
• The multi-year vesting schedule (three years) is typical for long-term incentive plans, aiming to retain executives and incentivize sustained performance, similar to compensation structures observed at peer companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aims to align executive performance with shareholder returns, potentially leading to increased long-term value. However, future exercise could lead to minor dilution.
• Employees: This is an executive-specific compensation, with no direct impact on the broader employee base, though it reflects the company's overall compensation philosophy for leadership.

Next Steps

• Robert Levy's continued service to Herbalife Ltd. through the vesting dates of February 25, 2027, February 25, 2028, and February 25, 2029, to realize the vesting of the SARs.
• Potential exercise of the SARs by Robert Levy at any point after vesting and before the expiration date of February 25, 2036, assuming the stock price is above the exercise price.

Key Dates

Keywords

Herbalife, HLF, Robert Levy, Stock Appreciation Rights, SARs, Executive Compensation, Insider Transaction, Form 4, Equity Incentive Plan